These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 535181)

  • 1. Metabolism of human beta 1H: studies in man and experimental animals.
    Charlesworth JA; Scott DM; Pussell BA; Peters DK
    Clin Exp Immunol; 1979 Dec; 38(3):397-404. PubMed ID: 535181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG; Liebowitch J; Amos N; Peters DK
    J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.
    Amos N; Sissons JG; Girard JF; Lachmann PJ; Peters DK
    Clin Exp Immunol; 1976 Jun; 24(3):474-82. PubMed ID: 939051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.
    Potter BJ; Elias E; Jones EA
    J Lab Clin Med; 1976 Sep; 88(3):427-39. PubMed ID: 956695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS
    J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.
    Lappin D; Moseley HL; Whaley K
    Clin Exp Immunol; 1980 Dec; 42(3):515-22. PubMed ID: 7011615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    Hong K; Kinoshita T; Kitajima H; Inoue K
    J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum C3-activating factor: its characterization and its presence in glomerular deposits.
    Roberts JL; Levy M; Chioros PG; Bartlow BG; Forristal J; West CD; Habib R; Lewis EJ
    J Immunol; 1981 Sep; 127(3):1131-7. PubMed ID: 7021675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of monocyte complement component synthesis by antigen--antibody complexes.
    McPhaden A; Lappin D; Whaley K
    Immunology; 1981 Sep; 44(1):193-200. PubMed ID: 7275185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA).
    Gaither TA; Hammer CH; Frank MM
    J Immunol; 1979 Sep; 123(3):1195-204. PubMed ID: 469245
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.
    Charlesworth JA; Williams DG; Sherington E; Lachmann PJ; Peters DK
    J Clin Invest; 1974 Jun; 53(6):1578-87. PubMed ID: 4830223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute local inflammation alters synthesis, distribution, and catabolism of third component of complement (C3) in rabbits.
    Manthei U; Strunk RC; Giclas PC
    J Clin Invest; 1984 Aug; 74(2):424-33. PubMed ID: 6746901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical Modelling of Alternative Pathway of Complement System.
    Bakshi S; Cunningham F; Nichols EM; Biedzka-Sarek M; Neisen J; Petit-Frere S; Bessant C; Bansal L; Peletier LA; Zamuner S; van der Graaf PH
    Bull Math Biol; 2020 Feb; 82(2):33. PubMed ID: 32062771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.